Market Closed -
Euronext Paris
11:35:11 2024-04-17 am EDT
5-day change
1st Jan Change
33.6
EUR
-1.03%
-1.32%
-16.46%
Boiron :
PROJECTED TIMETABLE OF THE NEXT PUBLICATIONS AND EVENTS 2022
June 28, 2021 at 09:05 am EDT
The projected timetable of the next publications and events for the year 2022 is the following one:
Publications Date of publication (after market closing) Information meetings
Annual sales of 2021
Quiet period from Wednesday, January 5, 2022
Thursday, January 20, 2022
Annual results of 2021
Quiet period from Monday, February 7, 2022
Wednesday, March 9, 2022
Thursday, March 10, 2022
1st quarter sales of 2022
Quiet period from Wednesday , April 6, 2022
Thursday, April 21, 2022
2022 Shareholders' Meeting
Thursday, May 19, 2022
Half-year sales of 2022
Quiet period from Wednesday, July 6, 2022
Thursday, July 21, 2022
Half-year results of 2022
Quiet period from Monday, August 8, 2022
Wednesday, September 7, 2022
Thursday, September 8, 2022
3rd quarter sales of 2022
Quiet period from Wednesday, October 5, 2022
Thursday, October 20, 2022
Quiet period: during the period prior to the publications, BOIRON limits its communication with the financial community.
Laboratoires BOIRON
Our next update: July 20, 2021: after the close of the stock market, publication of the sales on June 30, 2021.
Person responsible for financial information: Valérie Lorentz-Poinsot. boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg : BOI FP - Reuters : BOIR.PAwww.boironfinance.com
This publication embed "Actusnews SECURITY MASTER ". - SECURITY MASTER Key: l29yYclvY5eZyp9vZMlpamhsa2lnyGXGaWibmGJwmMuanWllnGmVZ5qeZm9qnWxs - Check this key: https://www.security-master-key.com .
Regulated information:
Full and original press release in PDF: https://www.actusnews.com/news/69876-gb_communique-calendrier-previsionnel-2022.pdf
Receive by email the next press releases of the company by registering on
www.actusnews.com , it's free © 2021 ActusNews
Boiron: nearly 600,000 shares tendered to the OPAS
Feb. 02
CF
Boiron: OPAS open from January 11 to 31
Jan. 11
CF
Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2023
23-09-10
CI
Oddo BHF Raises Boiron PT, Maintains Outperform Rating
23-09-07
MT
Boiron SA Board intends to launch an Equity Buyback on July 4, 2023.
23-07-04
CI
Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2022
23-03-22
CI
Boiron SA Recommends Dividend, Payable on June 3, 2023
23-03-20
CI
Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2022
22-09-15
CI
Global markets live: Novartis, Tesla, Disney, Sony, Walmart...
22-06-29
Galenica's Verfora To Take Over Distribution Of Boiron Products In Switzerland
22-06-29
MT
Boiron SA's Equity Buyback announced on February 7, 2022 has expired.
22-05-18
CI
Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2021
22-03-10
CI
Boiron SA completed the acquisition of 70% stake in Abbi.
22-02-27
CI
Boiron SA commences an Equity Buyback Plan for 1,727,496 shares, representing 9.85% for €87.73 million, under the authorization approved on May 27, 2021.
22-02-07
CI
Boiron SA signed an agreement to acquire 70% stake in Abbi for €1.8 million.
22-01-19
CI
Boiron Sa Reports Earnings Results for the Half Year Ended June 30, 2021
21-09-08
CI
Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2020
21-04-09
CI
French Agency for the Safety of Medicines and Health Products Selects Emmac Life Sciences Group in Partnership with Boiron as the Suppliers for the Forthcoming French Medical Cannabis Trial
21-01-26
CI
GLOBAL MARKETS LIVE: LVMH, Lululemon, Apple, Boeing…
20-09-09
Boiron SA Announces Unaudited Consolidated Earnings Results for the Year Ended December 31, 2019
20-04-21
CI
Boiron Sa Reports Earnings Results for the Half Year Ended June 30, 2019
19-09-03
CI
Boiron SA Reports Group Earnings Results for the Year Ended December 31, 2018
19-03-13
CI
GLOBAL MARKETS LIVE: Boeing, Blackstone, Adidas, Spotify, Apple…
19-03-13
Boiron SA Announces Proposes Dividend
18-12-11
CI
Boiron SA's Equity Buyback announced on March 30, 2018 has expired.
18-11-16
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues.
Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin.
There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties).
BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries.
Net sales are distributed geographically as follows: France (52.4%), Europe (22.5%), North America (22.6%) and other (2.5%).
More about the company
Last Close Price
33.6
EUR
Average target price
39.6
EUR
Spread / Average Target
+17.86%
Consensus
1st Jan change
Capi.
-16.46% 626M +37.12% 6B -14.61% 4.42B -10.58% 3.06B +0.86% 2.99B -0.94% 2.48B +36.18% 1.78B -10.82% 1.58B -4.89% 1.52B -12.50% 1.49B
Alternative Medicine
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
BOIRON 
